Literature DB >> 20498538

Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla.

Miriam A Bredella1, Reza Hosseini Ghomi, Bijoy J Thomas, Hugue A Ouellette, Dushyant V Sahani, Karen K Miller, Martin Torriani.   

Abstract

OBJECTIVE: To compare breath-hold 1H-magnetic resonance spectroscopy (1H-MRS) with respiratory-gated 1H-MRS and computed tomography (CT) for quantification of hepatic lipid content.
METHODS: Twenty-three premenopausal women underwent breath-hold point-resolved single-voxel 1H-MRS of the liver followed by respiratory-gated 1H-MRS at 3 Tesla and CT slice through the liver. Interscan variability for 1H-MRS was assessed in 6 volunteers. Pearson correlation coefficients, Bland-Altman 95% limit of agreement, and concordance correlation coefficients were calculated.
RESULTS: There was a strong correlation between breath-hold and respiratory-gated 1H-MRS (r = 0.94, P < 0.0001; concordance correlation coefficient, 0.75). Using Bland-Altman analysis, all but 2 data points were within the limits of agreement. Both 1H-MRS techniques had low interscan variability. There was an inverse correlation of both 1H-MRS techniques with CT attenuation values of the liver.
CONCLUSIONS: Breath-hold 1H-MRS is a reliable method to measure hepatic lipid content at 3 Tesla. Breath-hold 1H-MRS of the liver provides data that closely correlates with that obtained from longer-duration respiratory-gated technique.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498538      PMCID: PMC2877282          DOI: 10.1097/RCT.0b013e3181cefb89

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  36 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Prevalence of fatty liver in children and adolescents.

Authors:  Jeffrey B Schwimmer; Reena Deutsch; Tanaz Kahen; Joel E Lavine; Christina Stanley; Cynthia Behling
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

3.  Navigated single-voxel proton spectroscopy of the human liver.

Authors:  J M Tyszka; J M Silverman
Journal:  Magn Reson Med       Date:  1998-01       Impact factor: 4.668

4.  Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy.

Authors:  Jürgen Machann; Claus Thamer; Birgit Schnoedt; Norbert Stefan; Hans-Ulrich Haring; Claus D Claussen; Andreas Fritsche; Fritz Schick
Journal:  Magn Reson Med       Date:  2006-04       Impact factor: 4.668

5.  One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.

Authors:  Mary Ann Huang; Joel K Greenson; Cewin Chao; Lilian Anderson; Debra Peterman; Jon Jacobson; Dawn Emick; Anna S Lok; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

6.  Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo.

Authors:  L S Szczepaniak; E E Babcock; F Schick; R L Dobbins; A Garg; D K Burns; J D McGarry; D T Stein
Journal:  Am J Physiol       Date:  1999-05

7.  Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.

Authors:  Miriam A Bredella; Martin Torriani; Bijoy J Thomas; Reza Hosseini Ghomi; Danielle J Brick; Anu V Gerweck; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

8.  Abdominal adiposity and coronary heart disease in women.

Authors:  K M Rexrode; V J Carey; C H Hennekens; E E Walters; G A Colditz; M J Stampfer; W C Willett; J E Manson
Journal:  JAMA       Date:  1998-12-02       Impact factor: 56.272

9.  Study of aging of silicone rubber biomaterials with NMR.

Authors:  B Pfleiderer; P Xu; J L Ackerman; L Garrido
Journal:  J Biomed Mater Res       Date:  1995-09

10.  Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study.

Authors:  E L Thomas; G Hamilton; N Patel; R O'Dwyer; C J Doré; R D Goldin; J D Bell; S D Taylor-Robinson
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

View more
  18 in total

1.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Authors:  Miriam A Bredella; Eleanor Lin; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Martin Torriani; Bijoy J Thomas; David A Schoenfeld; Anne Breggia; Clifford J Rosen; Linda C Hemphill; Zida Wu; Nader Rifai; Andrea L Utz; Karen K Miller
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

2.  Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.

Authors:  Laurie R Braun; Meghan N Feldpausch; Natalia Czerwonka; Julian Weiss; Karen Branch; Hang Lee; Edgar L Martinez-Salazar; Martin Torriani; Craig A Sponseller; Steven K Grinspoon; Takara L Stanley
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

3.  Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women.

Authors:  Miriam A Bredella; Anu V Gerweck; Lauren A Barber; Anne Breggia; Clifford J Rosen; Martin Torriani; Karen K Miller
Journal:  Bone       Date:  2014-02-05       Impact factor: 4.398

4.  Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.

Authors:  Miriam A Bredella; Melanie Schorr; Laura E Dichtel; Anu V Gerweck; Brian J Young; Whitney W Woodmansee; Brooke Swearingen; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

5.  Effects of growth hormone withdrawal in obese premenopausal women.

Authors:  E Lin; M A Bredella; A V Gerweck; M Landa; D Schoenfeld; A L Utz; K K Miller
Journal:  Clin Endocrinol (Oxf)       Date:  2013-06       Impact factor: 3.478

6.  Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.

Authors:  Laurie R Braun; Meghan N Feldpausch; Natalia Czerwonka; Martin Torriani; Steven K Grinspoon; Takara L Stanley
Journal:  Growth Horm IGF Res       Date:  2017-10-07       Impact factor: 2.372

7.  Liver metabolite concentrations measured with 1H MR spectroscopy.

Authors:  Ronald Ouwerkerk; Roderic I Pettigrew; Ahmed M Gharib
Journal:  Radiology       Date:  2012-08-13       Impact factor: 11.105

8.  Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment.

Authors:  Norio Hayashi; Tosiaki Miyati; Takashi Minami; Yumie Takeshita; Yasuji Ryu; Tsuyoshi Matsuda; Naoki Ohno; Takashi Hamaguchi; Kenichiro Kato; Toshinari Takamura; Osamu Matsui
Journal:  Radiol Phys Technol       Date:  2012-12-07

9.  Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity.

Authors:  Miriam A Bredella; Corey M Gill; Anu V Gerweck; Melissa G Landa; Vidhya Kumar; Scott M Daley; Martin Torriani; Karen K Miller
Journal:  Radiology       Date:  2013-07-16       Impact factor: 11.105

10.  Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

Authors:  Takara L Stanley; Meghan N Feldpausch; Jinhee Oh; Karen L Branch; Hang Lee; Martin Torriani; Steven K Grinspoon
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.